---
title: "HWHG is in talks with JD Group for a full-chain collaboration in the pharmaceutical field"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251309667.md"
description: "HWHG and JD Group held a full-chain cooperation meeting in the pharmaceutical field at JD's headquarters on the afternoon of July 28. Both parties discussed the direction of deepening e-commerce cooperation, with HWHG presenting core demands, while the JD team stated that they would integrate marketing resources, optimize operational connections, and provide support in logistics technology and channel management"
datetime: "2025-08-03T03:33:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251309667.md)
  - [en](https://longbridge.com/en/news/251309667.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251309667.md)
generator: "portal-rs"
---

# HWHG is in talks with JD Group for a full-chain collaboration in the pharmaceutical field

On the afternoon of July 28, the Industrial Development Department/Business Coordination Department of China Merchants Group and China Merchants Innovation Technology jointly organized a visit by HWHG to the headquarters of JD Group. They held discussions with the JD Government and Enterprise, JD Health, and JD Logistics teams on deepening cooperation across the entire pharmaceutical supply chain. During the meeting, core business units under HWHG, including Yichang HWHG, Xinjiang Weiyuan, Gedian HWHG, HWHG Puke, Yichang Three Gorges Pharmaceutical, and Wuhan Tianrun, focused on their core demands for e-commerce development and proposed cooperation directions. The JD team responded positively, stating that they would integrate in-site marketing resources, optimize operational connections, provide data support, and assist in logistics technology, channel management, and vertical platform construction

### Related Stocks

- [600079.CN](https://longbridge.com/en/quote/600079.CN.md)

## Related News & Research

- [Humanwell unit Yichang Renfu wins China nod for labor pain trial of sufentanil injection](https://longbridge.com/en/news/295637927.md)
- [YUSHU TECHNOLOGY Founder Wang Xingxing Says Humanoid Robots' 'ChatGPT Moment' May Still Be a Decade Away; Nomura Initiates Coverage with Buy Rating](https://longbridge.com/en/news/296462640.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [China's Daqo New Energy Q2 revenue falls on weak demand](https://longbridge.com/en/news/296476125.md)
- [Innova Captab Revises FY26 Accounts and Clears Baddi Plant Expansion](https://longbridge.com/en/news/296661728.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**